DIALYSIS · CCN 212551

DaVita Greenspring Dialysis Center

BALTIMORE, MD 21215

DialysisProfitDaVita
$7.1M
TOTAL REVENUE
26.9%
OPERATING MARGIN
2 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$7.1M
Total costs
$5.2M
Operating income (rev − costs)
$1.9M
Operating margin
26.9%
Total charges
$7.2M
Total treatments
17,894
Dialysis stations
36

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.75135—
Fistula Rate
DFC_FISTULA_RATE
52.6147—
Five Star Rating
DFC_FIVE_STAR
2——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
0.7956—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
3——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
140.8124—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.51——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
21147—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
24.2526—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
18.3114—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
35.8102—
Standardized ED Visits Ratio
DFC_SEDR
0.9176—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
32.868—